‹ Screener

GAIA, INC

GAIA · Services-Motion Picture & Video Tape Production · 23.3M shares · +5%/yr ↑ shares · EDGAR filings ↗
Net buyback after stock comp: -$170K (gross $169K, SBC $339K)

Reference price $3.01 · est. market cap ~$70M — last insider purchase, 2026-03-18 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)

Grade

C58

Gaia Inc — conscious-media streaming service near breakeven.

Strengths

Risks

Notable findings

Quarterly revenue

2025-06-30 · $25M2025-09-30 · $25M2025-12-31 · $25M2026-03-31 · $24M

Last 4 quarters · from SEC filings.

Key metrics

Gross margin
87.1%
Operating margin
-5.2%
Net margin
-4.5%
Return on equity
-5.1%
Return on assets
-2.9%
ROIC
-4.3%
Revenue growth (QoQ)
-4.6%
Debt / equity
0.1×
Net debt / EBITDA
-2.7×
Current ratio
0.6×
Free cash flow
-$377K
EBITDA
$3M
Tangible book value
$39M
Cash & investments
$14M
Cash runway
144q
Stock comp / revenue
1.7%

Insider transactions · last 18 months

DateInsiderTypeSharesPrice
2026-06-16Sutherland Paul HowardGrant1.8K$2.40
2026-06-10Sutherland Paul HowardGrant2.5K$2.66
2026-06-09Sutherland Paul HowardGift175
2026-06-03Sutherland Paul HowardGrant5.6K$2.26
2026-05-29Sutherland Paul HowardGrant1.9K$2.37
2026-05-27Sutherland Paul HowardGrant1.2K$2.33
2026-05-22Sutherland Paul HowardGrant2.0K$2.49
2026-05-21Sutherland Paul HowardGrant1.0K$2.47
2026-05-15Sutherland Paul HowardGrant2.5K$2.37
2026-05-14Sutherland Paul HowardGrant1.5K$2.47
2026-05-12Sutherland Paul HowardGrant5.0K$2.36
2026-05-11RYSAVY JIRKAGrant21K$2.50
2026-05-11Preston NedGrant19K$2.50
2026-05-11Preston NedTax withheld6.3K$2.50
2026-05-11RYSAVY JIRKATax withheld6.2K$2.50
2026-05-11Medvedich KierstenGrant44K$2.50
2026-05-11Medvedich KierstenTax withheld12K$2.50
2026-05-08Sutherland Paul HowardGrant15K$2.44
2026-05-08RYSAVY JIRKAGrant40K$2.57
2026-04-23Frank Kristin E.Option exercise12K$3.00
2026-04-23Sutherland Paul HowardOption exercise14K$3.00
2026-03-31RYSAVY JIRKAGrant77K$2.77
2026-03-31Medvedich KierstenGrant35K$2.77
2026-03-31Medvedich KierstenTax withheld12K$2.77
2026-03-18Sutherland Paul HowardBuy2.0K$3.01
2026-03-17Sutherland Paul HowardBuy1.5K$3.07
2026-03-16Sutherland Paul HowardBuy5.5K$3.11
2026-03-13Sutherland Paul HowardBuy2.0K$3.07
2026-03-10Sutherland Paul HowardBuy10K$3.08
2026-03-06Sutherland Paul HowardBuy10K$3.15
2026-03-05Medvedich KierstenBuy1.5K$3.22
2026-03-05Nuta Yonathan AbrahamBuy1.5K$3.24
2025-12-22Sutherland Paul HowardBuy2.0K$3.70
2025-12-18Sutherland Paul HowardBuy1.5K$3.81
2025-12-16Sutherland Paul HowardBuy1.5K$4.14
2025-12-11Sutherland Paul HowardBuy1.5K$3.75
2025-12-10Sutherland Paul HowardBuy5.8K$3.71
2025-12-09Sutherland Paul HowardBuy150$3.53
2025-12-09Sutherland Paul HowardBuy1.5K$3.53
2025-12-09Sutherland Paul HowardBuy300$3.53
2025-12-08Sutherland Paul HowardBuy2.8K$3.57
2025-12-08Sutherland Paul HowardBuy975$3.56
2025-12-08Nuta Yonathan AbrahamBuy1.0K$3.40
2025-12-08Nuta Yonathan AbrahamBuy1.0K$3.45
2025-12-08Nuta Yonathan AbrahamBuy2.0K$3.53
2025-09-09Medvedich KierstenBuy2.8K$5.60
2025-09-05Preston NedBuy500$5.69
2025-09-05Preston NedBuy1.5K$5.62
2025-05-20Frank Kristin E.Option exercise14K$4.43
2025-05-20Sutherland Paul HowardOption exercise17K$4.43
2025-05-08AWM Investment Company, Inc.Sell10K$5.21
2025-05-07AWM Investment Company, Inc.Sell10K$5.13

All non-derivative Form 4 activity (SEC), newest first.

Clinical trials

TrialTitlePhaseStatusPrimary completion
NCT05535231 ↗A Study to Evaluate the Effect of Turmeric in Healthy Participants
Healthy
NACompleted2022-10-03
NCT05207371 ↗Clinical Trial of GAIA-102 for Advanced and Relapse NSCLC
Cell Therapy, NSCLC
PHASE1/PHASE2Unknown2022-10-01
NCT05076890 ↗Hemp 15 mg & 50 mg Capsule Absorption
Absorption; Chemicals
NACompleted2022-03-26

Source: ClinicalTrials.gov (U.S. NIH) · active studies first.

Supply chain

Customers (0)

    Suppliers (2)

    Named in the 10-K; linked when we track them.

    Notable events (8-K)

    DateItems
    2026-05-04ResultsExhibitsfiling ↗
    2026-04-29Shareholder votefiling ↗
    2026-03-02ResultsExhibitsfiling ↗
    2025-11-03ResultsExec/director changeExhibitsfiling ↗
    2025-08-11ResultsExhibitsfiling ↗
    2025-07-30Material agreementExhibitsfiling ↗
    2025-06-30Exec/director changeExhibitsfiling ↗
    2025-05-13Exec/director changeShareholder votefiling ↗

    Recent filings

    FormFiledPeriodAccession
    8-K2026-05-042026-05-040001193125-26-203970 ↗
    10-Q2026-05-042026-03-310001193125-26-203986 ↗
    8-K2026-04-292026-04-230001193125-26-192213 ↗
    10-K2026-03-062025-12-310001193125-26-096522 ↗
    8-K2026-03-022026-03-020001193125-26-085353 ↗
    10-Q2025-11-042025-09-300001193125-25-263669 ↗
    8-K2025-11-032025-11-030001193125-25-262553 ↗
    10-Q2025-08-112025-06-300000950170-25-106575 ↗
    8-K2025-08-112025-08-110000950170-25-106543 ↗
    8-K2025-07-302025-07-290000950170-25-100221 ↗
    8-K2025-06-302025-06-260000950170-25-091233 ↗
    8-K2025-05-132025-05-080000950170-25-070334 ↗